Q2 2019 Holdings
Filed 2019-08-14 | 63 holdings | $3.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Recro Pharma Inc | COM | 75629F109 | $115 | 11,353 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $221 | 4,883 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $241 | 2,111 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $244 | 11,440 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $254 | 3,012 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $257 | 1,397 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $276 | 4,082 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $278 | 13,196 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $319 | 1,985 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $322 | 5,064 | 0.0% |
| BIO Techne Corp(TECH) | COM | 09073M104 | $323 | 1,551 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $323 | 16,641 | 0.0% |
| Checkpoint Therapeutics Inc(CKPTUSD) | COM | 162828107 | $342 | 112,760 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $345 | 6,116 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $351 | 234,030 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $374 | 3,570 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $402 | 48,485 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $420 | 18,631 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $445 | 12,503 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $458 | 36,731 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $465 | 9,725 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $466 | 28,490 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $467 | 5,872 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $475 | 10,852 | 0.0% |
| Pacira Biosciences(PCRX) | COM | 695127100 | $489 | 11,250 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $499 | 9,479 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $510 | 30,075 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $520 | 5,625 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $573 | 9,770 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $622 | 13,214 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $632 | 50,378 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $633 | 3,674 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $639 | 20,844 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $640 | 6,780 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $656 | 17,339 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $690 | 26,936 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $695 | 2,221 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $743 | 5,840 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $813 | 5,353 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $868 | 62,575 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $902 | 10,613 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $993 | 9,699 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.0K | 8,534 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.1K | 14,215 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $1.2K | 28,858 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $1.2K | 17,901 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.3K | 138,461 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.3K | 20,124 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $1.3K | 9,927 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $1.5K | 33,000 | 0.0% |